Introduction:
The State of North Carolina and Fresenius Kabi have announced their plans to expand the pharmaceutical manufacturing unit in Wilson.
Features:
Fresenius Kabi is investing more than US$100 million in the expansion of their manufacturing unit. The expansion would create 445 new jobs over the span of five years in the region.
On its completion, the unit is expected to increase its manufacturing capacity for generic drugs in ready-to-administer pre-filled syringes.
Fresenius Kabi in North Carolina plans to expand its existing pharmaceutical production department along with the construction of a new manufacturing unit at Wilson.
This project will help to manufacture products which will be utilised in hospitals and clinics throughout Canada and the United States.
This expansion will be supporting the production of the syringes that will help to eradicate medical errors by reducing the number of steps involved, while injecting patients.
With this expansion of pharmaceutical manufacturing unit, products and operations will meet the requirements of the customers to make health care more accessible for patients.
Manufacturing represents 22 percent of state’s economic output making North Carolina , one of the country’s largest centers for biotechnology.
Specifications:
| Name | Fresenius Kabi |
| Location | Wilson, North Carolina. USA |
| Type | Expansion |
| Parties Involved | State of North Carolina and Fresenius Kabi |
| Budget | US$100 million |
